Newsmeme!
Discover News you didn't know existed
Merck KGaA and its Merck Serono division announced that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination with radiotherapy for locally advanced ...
No tags found at this time. Be the first to tag this news item, learn more.
No related imagery found.
No related news stories found.
Prophylactic cranial radiotherapy (PCR) : Cancerbackup
Why won't our doctors face up to the dangers of radiotherapy? | Mail Online
New accelerator enhances radiotherapy accuracy - physicsworld.c om
IAEA - Imaging in Radiotherapy
Spezi and Lewis - An overview of Monte Carlo treatment planning for radiotherapy -- 131 (1): 123 -- Radiat Prot Dosimetry: Introductory article
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |